Elimusertib has Antitumor Activity in Preclinical Patient-Derived Pediatric Solid Tumor ModelsFabian F. Pusch, Anton G. Henssen|Molecular Cancer Therapeutics|2023Cited by 17
Elimusertib outperforms standard of care chemotherapy in preclinical patient-derived pediatric solid tumor modelsFabian F. Pusch, Anton G. Henssen|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 3